An AI-powered drug discovery platform focused on finding treatments for rare diseases.
Healx is listed on Rocketlist with 1 active role. The company is categorized as AI-driven Drug Discovery in BioTech. Healx is at Series C stage, with a B2B business model, headquartered in Cambridge, United Kingdom. Healx was founded in 2014 and has 63 employees. Healx has raised $110M. Active roles are refreshed daily from public hiring sources.